112574 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER
#2Methods and monitoring of treatment with lanifibranor
#3APPARATUS AND METHODS USING TETHERED ENZYMES FOR THE DETECTION OF THE ENZYMATIC ACTIVITY OF BIOMARKERS
#4Protein array-based in vitro transglutaminase assay platform for epitope mapping and immunogen design
#5COMPOSITIONS CONTAINING CHOLINE PROPIONATE FOR CONTROLLING GROWTH OF MOLD AND IMPROVING ANIMAL PERFORMANCE AND RELATED METHODS
#6METHODS FOR DETERMINING AND/OR MONITORING THE HEALTH STATUS OF FISH
#7ESM1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#8SFLT1 MARKER PANELS FOR EARLY DETECTION OF SEPSIS
#9Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers
#10MICROFLUIDIC DEVICES AND RAPID PROCESSING THEREOF
#11PRESERVATIVE FOR IN VITRO DIAGNOSTIC REAGENT AND USE THEREOF
#12SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#13Systems and methods for multi-analysis
#14Quantification method of ethanolamine phosphate, oxidoreductase for quantification, composition for quantification, kit for quantification and sensor for quantification
#15Systems and methods for sample use maximization
#16METHODS OF DETECTING AMINO ACID DEFICIENCIES
#17Method for quantification of amino acids using cell-free protein synthesis system
#18Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity
#19SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#20NOVEL USES OF CATALYTIC PROTEIN
#21Blood analysis method and blood test kit
#22Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#23SYSTEMS AND METHODS FOR ELECTROCHEMICAL ASPARTATE TRANSAMINASE (AST) AND ALANINE TRANSAMINASE (ALT) DETECTION AND QUANTIFICATION
#24Method for performing multiple enzyme reactions in a single tube
#25Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#26DEVICE FOR ONLINE MEASUREMENT OF NEUROTRANSMITTERS USING ENZYMATIC REACTORS
#27Systems and methods for sample use maximization
#28Method for measuring ethanolamine phosphate
#29Systems and methods for electrochemical aspartate transaminase (AST) and alanine transaminase (ALT) detection and quantification
#30APPARATUSES FOR DETECTING DEGRADED TEST CHEMICALS IN ANALYTICAL TEST ELEMENTS
#31Treatment of hepatitis delta virus infection
#32SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#33Systems and methods for multi-analysis
#34Systems and methods for sample use maximization
#35SYSTEMS AND METHODS FOR MULTI-ANALYSIS
#36Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#37Method for measuring ethanolamine phosphate
#38Systems and methods for multi-analysis
#39Systems and methods for sample use maximization
#40Systems and methods for multi-analysis
#41Systems and methods for multi-analysis
#42Systems and methods for multi-analysis
#43Systems and methods for sample use maximization
#44Systems and methods for multi-analysis
#45Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method
#46Systems and methods for sample use maximization
#47Device for online measurement of neurotransmitters using enzymatic reactors
#48Method of Determining Hypoxia
#49Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
#50Systems and methods for multi-analysis
#51Methods of measuring analytes that include a test element quality measurement based upon intrinsic luminescence of a test chemical of the test element
#52Use of photocleavable compounds
#53BIOMARKER FOR FATIGUE, AND USE THEREOF
#54MARKER FOR DETECTION AND/OR DISCRIMINATION OF NON-ALCOHOLIC STEATOHEPATITIS, METHOD FOR DETECTION AND/OR DISCRIMINATION OF NON-ALCOHOLIC STEATOHEPATITIS, AND KIT FOR USE IN THE METHOD
#55Stabilized open form transglutaminase as a diagnostic indictor for autoimmune diseases
#56SYSTEMS AND METHODS FOR SAMPLE USE MAXIMIZATION
#57Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#58Targets for Growth Factor Signalling and Methods of Therapy
#59METHOD FOR DETECTING HEPATIC INJURY DUE TO ANTITHYROID DRUG
#60METHOD OF DETERMINING ALANINE TRANSAMINASE (ALT) ACTIVITY BY 13C-MR DETECTION USING HYPERPOLARISED 13C-PYRUVATE
#61ASSAYS FOR S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASES
#62Detection of hepatotoxic cyanobacteria
#63Method of determining hypoxia
#64Effects of tissue transglutaminase on beta-amyloid-induced apoptosis
#65Agent for assaying analyte of patient by enzyme
#66Spectroscopic analysis of a biological fluid reacted with an enzyme
#67Method for screening transglutaminase 2 inhibitor or activator
#68Microchip-based system for hiv diagnostics
#69Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#70GABA detection methods and applications
#71Protein markers for pharmaceuticals and related toxicity
#72Reagent for measuring alanine aminotransferase activity